Literature DB >> 19588731

Serum transaminases concentrations in obese children and adolescents.

E M González-Gil1, G Bueno-Lozano, O Bueno-Lozano, L A Moreno, L Cuadrón-Andres, P Huerta-Blas, J M Garagorri, M Bueno.   

Abstract

The aim of the study was to investigate the relationship between liver transaminase levels and metabolic syndrome (MS) features in obese children and adolescents. A total of 132 children and adolescents (73 males and 59 females) aged 8 - 16, participated in the study. All were studied at the department of Paediatrics, University Hospital of Zaragoza (Spain). Inclusion criteria were the existence of obesity as defined by body mass index (BMI) according to Cole cut-off values (when BMI was higher than the age and sex specific equivalent to 30 kg/m2). The definition of metabolic syndrome was according to the International Diabetes Federation criteria. Weight (kg), height (cm), waist circumference (cm), blood pressure and BMI were measured. Laboratory determinations after overnight fasting included: transaminases (ALT, AST, GGT), fasting glucose, insulin, triglycerides and HDL-C. The MS was found in 21.6% of the obese children and adolescents and the prevalence was higher in males (25.9%) than in females (15.9%). Serum transaminases (ALT, AST and GGT) mean concentrations were higher in males than in females, and decreased during pubertal development. The obese children and adolescents with the MS did not show higher transaminases concentrations when compared with those without the MS. Some MS manifestations (mainly waist circumference) showed a correlation with ALT, although all transaminases values were normal according to adult references. Liver transaminases, a surrogate marker of NAFLD, did not show an early and consistent manifestation of abnormalities in the obese children and adolescents studied. In order to define the presence of the disease, it would be necessary to obtain aminotransferase reference standards for children and adolescents, considering pubertal stage and gender.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19588731     DOI: 10.1007/bf03165969

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  37 in total

1.  Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging.

Authors:  Giorgio Radetti; Wolfgang Kleon; Joseph Stuefer; Klaus Pittschieler
Journal:  Acta Paediatr       Date:  2006-07       Impact factor: 2.299

2.  Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease.

Authors:  Mark H Fishbein; Chris Mogren; Theodore Gleason; W Ross Stevens
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-01       Impact factor: 2.839

3.  Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Stephen Cook; Michael Weitzman; Peggy Auinger; Michael Nguyen; William H Dietz
Journal:  Arch Pediatr Adolesc Med       Date:  2003-08

4.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

Authors:  Allison A Hedley; Cynthia L Ogden; Clifford L Johnson; Margaret D Carroll; Lester R Curtin; Katherine M Flegal
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

5.  Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey.

Authors:  Sarah D de Ferranti; Kimberlee Gauvreau; David S Ludwig; Ellis J Neufeld; Jane W Newburger; Nader Rifai
Journal:  Circulation       Date:  2004-10-11       Impact factor: 29.690

6.  [Metabolic syndrome in overweight and obese schoolchildren in Beijing].

Authors:  Nai-jun Wan; Jie Mi; Tian-you Wang; Jia-li Duan; Ming Li; Chun-xiu Gong; Jun-bao Du; Xiao-yuan Zhao; Hong Cheng; Dong-qing Hou; Li Wang
Journal:  Zhonghua Er Ke Za Zhi       Date:  2007-06

7.  Relationship of liver enzymes to insulin sensitivity and intra-abdominal fat.

Authors:  Tara M Wallace; Kristina M Utzschneider; Jenny Tong; Darcy B Carr; Sakeneh Zraika; Daniel D Bankson; Robert H Knopp; Steven E Kahn
Journal:  Diabetes Care       Date:  2007-07-31       Impact factor: 19.112

Review 8.  Fatty liver: a novel component of the metabolic syndrome.

Authors:  Anna Kotronen; Hannele Yki-Järvinen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-09       Impact factor: 8.311

9.  The prevalence and etiology of elevated aminotransferase levels in the United States.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

10.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06
View more
  4 in total

1.  Abdominal fat and metabolic risk in obese children and adolescents.

Authors:  J Revenga-Frauca; E M González-Gil; G Bueno-Lozano; P De Miguel-Etayo; P Velasco-Martínez; J P Rey-López; O Bueno-Lozano; L A Moreno
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

2.  Inhibitory effects of estrogens on digestive enzymes, insulin deficiency, and pancreas toxicity in diabetic rats.

Authors:  Khaled Hamden; Bassem Jaouadi; Nedia Zaraî; Tarek Rebai; Serge Carreau; Abdelfattah Elfeki
Journal:  J Physiol Biochem       Date:  2010-11-16       Impact factor: 4.158

3.  Cut-Off Values of Visceral Adiposity to Predict NAFLD in Brazilian Obese Adolescents.

Authors:  Ana Paula Grotti Clemente; Bárbara Dal Molin Netto; Aline di Piano Ganen; Lian Tock; Danielle Arisa Caranti; Marco Túlio de Mello; Sergio Tufik; Ana R Dâmaso
Journal:  J Nutr Metab       Date:  2013-12-07

4.  Associations of matrix metalloproteinase (MMP)-8, MMP-9, and their inhibitor, tissue inhibitor of metalloproteinase-1, with obesity-related biomarkers in apparently healthy adolescent boys.

Authors:  Youn Ho Shin; Ki Eun Kim; Yong-Jae Lee; Jae-Hwan Nam; Young Mi Hong; Hye-Jung Shin
Journal:  Korean J Pediatr       Date:  2014-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.